Effects of TES Program on Exercise Capacity, Self-Efficacy and Patient Compliance in Patients with Myocardial Infarction.
10.4040/jkan.2003.33.7.905
- Author:
Jina CHOO
1
;
Ja Mae KIM
;
Kyung Pyo HONG
Author Information
1. Postdoctoral Fellow School of Nursing, University of Pittsburgh, USA. jinachoo@pitt.edu
- Publication Type:Original Article ; English Abstract
- Keywords:
Cardiac rehabilitation;
Exercise;
Self-efficacy;
Social support;
Patient compliance
- MeSH:
Anaerobic Threshold;
Cardiovascular Nursing;
Compliance;
Humans;
Methods;
Mortality;
Myocardial Infarction*;
Patient Compliance*;
Stroke Volume
- From:
Journal of Korean Academy of Nursing
2003;33(7):905-916
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study aimed to develop a TES program to improve exercise capacity to promote patient compliance to the prescribed exercise, and to test the feasibility of the program. METHOD: The 8-week TES program consisted of three components : exercise training, self-efficacy enhancement and social support. Using the matching of gender, age, and the left ventricular ejection fraction, thirty one subjects were consecutively assigned to either TES group (n=15, 52+7 years) or Control group (n=16, 58+11 years) 3 weeks after MI. With the exception of exercise compliance (only after the TES program), the exercise capacity and exercise self-efficacy were both measured both before and after the 8-week TES program. RESULT: The VO2peak (p= .043), anaerobic threshold (p= .023) and exercise duration (p= .015) improved in TES group compared to Control group after 8 weeks. The cardiac exercise self-efficacy (p= .036) was significantly higher in TES group than Control group. There was a significant increase of exercise compliance(p= .005) in TES group compared to Control group. CONCLUSION: The 8-week TES program improved the exercise capacity, exercise self-efficacy and exercise compliance. A appropriately implemented TES program in cardiovascular nursing practice may promote healthy behavioral modification and, therefore, contributing to reduce the risk of mortality and morbidity in MI patients.